These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 20588187)
21. Method optimization to assess endothelial function in females-duration of glyceryl trinitrate effect. Ibrahim NN; Rasool AH; Wong AR; Rahman AR Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):349-52. PubMed ID: 17805437 [TBL] [Abstract][Full Text] [Related]
22. Rapid development of nitrate tolerance in healthy volunteers: assessment using spectral analysis of short-term blood pressure and heart rate variability. Cloarec-Blanchard L; Funck-Brentano C; Carayon A; Jaillon P J Cardiovasc Pharmacol; 1994 Aug; 24(2):266-73. PubMed ID: 7526059 [TBL] [Abstract][Full Text] [Related]
23. Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers. Tabone X; Funck-Brentano C; Billon N; Jaillon P Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):672-9. PubMed ID: 7995010 [TBL] [Abstract][Full Text] [Related]
24. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris]. Kośmicki MA; Skorykow-Sapińska A; Sadowski Z Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156 [TBL] [Abstract][Full Text] [Related]
25. Lack of cross-tolerance to short-term linsidomine in forearm resistance vessels and dorsal hand veins in subjects with nitroglycerin tolerance. Sütsch G; Kim JH; Bracht C; Kiowski W Clin Pharmacol Ther; 1997 Nov; 62(5):538-45. PubMed ID: 9390110 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and biochemical effects of 100% oxygen breathing in humans. Milone SD; Newton GE; Parker JD Can J Physiol Pharmacol; 1999 Feb; 77(2):124-30. PubMed ID: 10535703 [TBL] [Abstract][Full Text] [Related]
27. Dose-response relationship of sublingual nitroglycerin with brachial artery dilatation and change in central and peripheral augmentation index. Oliver JJ; Bowler A; Beudeker Q; Cate Tt; Webb DJ Clin Pharmacol Ther; 2005 Apr; 77(4):337-8. PubMed ID: 15903132 [No Abstract] [Full Text] [Related]
28. The angiotensin II-receptor antagonist losartan does not prevent hemodynamic or vascular tolerance to nitroglycerin. Milone SD; Azevedo ER; Forster C; Parker JD J Cardiovasc Pharmacol; 1999 Nov; 34(5):645-50. PubMed ID: 10547079 [TBL] [Abstract][Full Text] [Related]
29. Effects of sublingual nitroglycerin in patients receiving transdermal nitroglycerin for coronary artery disease: prevention of cross-tolerance. Naito H; Matsuda Y; Yorozu T; Shiomi K; Maeda T; Seki K; Tada T; Fujii H Clin Cardiol; 1991 Aug; 14(8):644-50. PubMed ID: 1914267 [TBL] [Abstract][Full Text] [Related]
30. Investigation of endothelial function by pulse contour analysis: a protocol for drug administration and timing of pulse contour assessment. Gordon SE; Cartwright N; Griffiths MJ Br J Clin Pharmacol; 2009 Oct; 68(4):630-3. PubMed ID: 19843066 [TBL] [Abstract][Full Text] [Related]
31. Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance. Milone SD; Pace-Asciak CR; Reynaud D; Azevedo ER; Newton GE; Parker JD J Cardiovasc Pharmacol; 1999 May; 33(5):685-90. PubMed ID: 10226853 [TBL] [Abstract][Full Text] [Related]
33. Effects of stimulation of nitric oxide synthesis on large artery stiffness in patients with peripheral arterial disease. Kals J; Kampus P; Kals M; Pulges A; Teesalu R; Zilmer M Atherosclerosis; 2006 Apr; 185(2):368-74. PubMed ID: 16051250 [TBL] [Abstract][Full Text] [Related]
34. Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin. Parker JD; Farrell B; Fenton T; Parker JO J Am Coll Cardiol; 1992 Sep; 20(3):616-22. PubMed ID: 1512341 [TBL] [Abstract][Full Text] [Related]
35. Responsiveness of peripheral veins to transdermal and sublingual nitroglycerin in healthy male volunteers. Hiremath AN; Hoffman BB; Blaschke TF J Cardiovasc Pharmacol; 1989 Oct; 14(4):534-41. PubMed ID: 2478766 [TBL] [Abstract][Full Text] [Related]
36. Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects. Ducharme A; Dupuis J; McNicoll S; Harel F; Tardif JC Am J Cardiol; 1999 Oct; 84(8):952-4, A8. PubMed ID: 10532523 [TBL] [Abstract][Full Text] [Related]
37. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure. Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435 [TBL] [Abstract][Full Text] [Related]
38. Methionine restores the venodilative response to nitroglycerin after the development of tolerance. Levy WS; Katz RJ; Wasserman AG J Am Coll Cardiol; 1991 Feb; 17(2):474-9. PubMed ID: 1899435 [TBL] [Abstract][Full Text] [Related]
39. The haemodynamic effects of sublingual nitroglycerin spray in severe left ventricular failure. Edwards JD; Grant PT; Plunkett P; Nightingale P Intensive Care Med; 1989; 15(4):247-9. PubMed ID: 2501371 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of tolerance during treatment with nitroglycerin patches for 24 h. Klemsdal TO; Mundal HH; Gjesdal K Eur J Clin Pharmacol; 1996; 51(3-4):227-30. PubMed ID: 9010689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]